Gastric TFF1 Expression from Acute to Chronic Helicobacter Infection

Frontiers in Cellular and Infection Microbiology
Roberta EspositoAlessandra Tosco

Abstract

TFF1, a mucin-associated secreted peptide of gastric mucous cells, is known as a protective agent for stomach epithelium under different stimuli, but its role upon Helicobacter infection is still not clear. In this paper we characterized TFFs expression, with particular attention to TFF1, under Helicobacter infection in gastric cell lines. A mouse model was used to distinguish TFF1 mRNA expression between acute and chronic stages of Helicobacter infection. Our results show that TFF1 expression is induced in infected cells; in addition, the inflammatory response upon Helicobacter infection is inversely associated to pre-existing TFF1 protein levels. In infected mice, TFF1 is initially upregulated in gastric antrum in the acute phase of infection, along with IL-1β and IL-6. Then, expression of TFF1 is gradually silenced when the infection becomes chronic and IFN-γ, CXCL5, and CXCL15 reach higher levels. Our data suggest that TFF1 might help cells to counteract bacteria colonization and the development of a chronic inflammation.

References

Apr 15, 1985·The Medical Journal of Australia·B J MarshallR J Glancy
Oct 13, 2000·Gastroenterology Clinics of North America·J R Warren
Jun 11, 2002·Biochemical and Biophysical Research Communications·Clemens J BulittaTimothy C Wang
Oct 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ralph CarvalhoJosé Carlos Machado
Apr 23, 2005·Infection and Immunity·Zhannat Z NurgalievaDavid Y Graham
Jul 1, 2005·Digestive Diseases and Sciences·Jeroen H B Van De BovenkampJan Dekker
Jan 24, 2007·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Julia M SchmitzRobin G Lorenz
Mar 27, 2007·Best Practice & Research. Clinical Gastroenterology·Karen RobinsonJohn C Atherton
Dec 23, 2008·Cellular and Molecular Life Sciences : CMLS·S Kjellev
May 22, 2009·Gastroenterology·Timothy L Cover, Martin J Blaser
Mar 10, 2010·Cellular and Molecular Life Sciences : CMLS·Alessandra ToscoLiberato Marzullo
Sep 28, 2012·Methods in Molecular Biology·Arlin B Rogers
Sep 18, 2013·Helicobacter·Xavier CalvetFrancis Mégraud
Nov 13, 2013·Cancers·Yoku HayakawaTimothy C Wang
Nov 16, 2013·PloS One·Sandro MontefuscoMarguerite Clyne
Dec 24, 2013·World Journal of Gastroenterology : WJG·Ko Eun LeeYoung Do Jung
Mar 22, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ana FerroNuno Lunet
May 17, 2014·World Journal of Gastroenterology : WJG·Camila A FigueiredoNeuza M Alcantara-Neves
Dec 9, 2014·The International Journal of Biochemistry & Cell Biology·Roberta EspositoLiberato Marzullo
Aug 13, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ping XiaoRuirui Yang
Jul 28, 2016·Scientific Reports·Yong SunXiangdong Deng
Dec 20, 2016·Annual Review of Physiology·Eitaro AiharaMarshall H Montrose

❮ Previous
Next ❯

Citations

Dec 22, 2019·The FEBS Journal·Roberta EspositoAlessandra Tosco
Jul 13, 2018·International Journal of Molecular Sciences·Elena RomanoAlessandra Tosco
Mar 7, 2021·International Journal of Molecular Sciences·Daniela ElettoAlessandra Tosco

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
PCR
Assay
light microscopy

Software Mentioned

ImageQuant TL
PRISM4
ImageQuant
GraphPad

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here